Images
2009_Biosimilars in Europe and the US (DAFSA).qxd
An in-depth look at biosimilars — for growth hormone, somatostatin and analogues, erythropoietin, insulin, infertility drugs, G-CSF growth factors, interferons, coagulation factors, and bio-oncology drugs — in nine European countries and the United States. BIOSIMILARS IN EUROPE AND THE UNITED
BRICMT_5.qxd
IHS Global Insight’s latest multi-client study provides a comprehensive overview of the drug markets and associated regulations in BRIC-MT countries (Brazil, Russia, India, China, Mexico, and Turkey). Our primary research and market analysis helps organizations explore the opportunities for
Manufacturers in every industry are challenged to manage the opportunities and risks of developing...
Manufacturers in every industry are challenged to manage the opportunities and risks of developing successful products in today’s stressed economic climate. Companies around the world are under pressure to innovate, improve quality and reduce costs as technology continues to advance, supply chains
Microsoft Word - EUPVfrontPagev5.docx
New Market Study Study Now Available for Downloading: See page four for order information 700 TECHNOLOGY SQUARE | CAMBRIDGE, MA 02139 USA PASEO DE GRACIA 47, PLANTA 2 | BARCELONA, SPAIN 08007 TEL: +1 617 551 8580 | FAX: +1.617 551 8481 TEL: +34 93 272 6777 | FAX: +34 93 467 6754 STUDY
Page:
